Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2124-2016Class II

Magnetic Resonance System G-scan Brio (Part Number /Model No.101002000)

Esaote S.p.A. / initiated 2016-06-06 / Terminated

Esaote S.p.A. began a recall of Magnetic Resonance System G-scan Brio (Part Number /Model No.101002000) on . FDA classified it as Class II and gives the reason as "The device is being recalled because dynamic loading forces from larger patients can fracture the extremity portion of the patient table. Additionally, a weight limit is added to the patient seat for weight-bearing...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2124-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Esaote S.p.A.
Product
Magnetic Resonance System G-scan Brio (Part Number /Model No.101002000)
Product code
LNH System, Nuclear Magnetic Resonance Imaging
Reason for recall
The device is being recalled because dynamic loading forces from larger patients can fracture the extremity portion of the patient table. Additionally, a weight limit is added to the patient seat for weight-bearing examinations.
FDA root cause
Other
Action
Esaote initiated a voluntary recall of the G-scan Brio Magnetic Resonance System on 06/06/2016 with letters sent via certified, due to a potential weakness on the extremity areas of the patient table that could lead to a stress fracture of the table. The firm has instructed customers to refer to the Medical Device Safety Notification provided with the recall notice, date and sign this letter in the space provided on the last page and send it back via email to [email protected]. If customers have questions regarding the recall, please call 1-317-813-6030. For additional information, please contact us by phone during normal business hours, Monday-Friday from 8:00am 5:00pm Eastern Standard Time, via email at [email protected], or at any time by visiting our website. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online at www.fda.gov/medwatch/report.htm, by regular mail using the postage-paid, pre-addressed Form FDA3500 available at www.fda.gov/MedWatchgetforms.htm or by fax to 1-800-FDA-0178.
Quantity in commerce
11 USA; 29 OUS
Distribution
Domestic: FL, TX, OH, MN, NV; Foreign: No customers in Canada; No VA/DOD.
Product codes and lots
Item No., Unit Description and Serial No.s: 101002000, UNIT, G-SCAN BRIO, 05202; 101002000, UNIT, G-SCAN BRIO, 05203; 101002000, UNIT, G-SCAN BRIO 2.1A; 05205; 101002000, UNIT, G-SCAN BRIO 2.1A, 05207; 101002000 UNIT, G-SCAN BRIO 2.1A, 05208; 101002000 UNIT, G-SCAN BRIO 2.1A, 05209; 101002000 UNIT, G-SCAN BRIO 2.1A, 05210; 101002000 UNIT, G-SCAN BRIO 2.1A, 05211; 101002000 UNIT, G-SCAN BRIO 2.1A, 05305; 101002000 UNIT, G-SCAN BRIO 2.1A, 05308

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2124-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2124-2016Class IITerminatedVoluntary: Firm initiated